VYNE Therapeutics Inc. (VYNE)

VYNE Therapeutics Revenue

VYNE Therapeutics had revenue of $202.00K in the quarter ending March 31, 2025, with 106.12% growth. This brings the company's revenue in the last twelve months to $605.00K, up 43.03% year-over-year. In the year 2024, VYNE Therapeutics had annual revenue of $501.00K with 18.16% growth.

• Revenue (ttm): $605.00K
• Revenue Growth: +43.03%
• P/S Ratio: 24.86
• Revenue / Employee: $46,538
• Employees: 13
• Market Cap: 5.88M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	501.00K	77.00K	18.16%
Dec 31, 2023	424.00K	-53.00K	-11.11%
Dec 31, 2022	477.00K	-454.00K	-48.76%
Dec 31, 2021	931.00K	-20.06M	-95.57%
Dec 31, 2020	20.99M	20.55M	4,638.83%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.